Immunoinformatics-Based development of a Multi-Epitope vaccine candidate targeting coinfection by Klebsiella pneumoniae and Acinetobacter baumannii

Abstract Background The increasing prevalence of multidrug-resistant (MDR) pathogens in clinical settings underscores the urgent need for effective therapeutic strategies. Among these, ESKAPE pathogens such as Acinetobacter baumannii and Klebsiella pneumoniae are particularly concerning due to their...

Full description

Saved in:
Bibliographic Details
Main Authors: Gul Afshan, Namrah Yaseen, Syed H Ali, Asad U. Khan
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-025-11242-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849403259669708800
author Gul Afshan
Namrah Yaseen
Syed H Ali
Asad U. Khan
author_facet Gul Afshan
Namrah Yaseen
Syed H Ali
Asad U. Khan
author_sort Gul Afshan
collection DOAJ
description Abstract Background The increasing prevalence of multidrug-resistant (MDR) pathogens in clinical settings underscores the urgent need for effective therapeutic strategies. Among these, ESKAPE pathogens such as Acinetobacter baumannii and Klebsiella pneumoniae are particularly concerning due to their ability to cause severe co-infections with high resistance profiles. Methods This study utilized an immunoinformatics-driven approach to design a novel multi-epitope vaccine targeting surface proteins of these pathogens through reverse vaccinology. Computational analyses employed bioinformatics tools, including NetCTLpan 1.1, IEDB T-cell epitope prediction tool, BCPREDS, ExPASy ProtParam, Rosetta, GalaxyRefine, HADDOCK, Disulfide by Design 2, and JCAT. Results Six cytotoxic T lymphocyte (CTL), six helper T lymphocyte (HTL), and six B-cell epitopes were identified as non-allergenic, non-toxic, and highly antigenic. These epitopes were linked using GPGPG and EAAAK linkers to enhance structural flexibility and immunogenicity. The vaccine’s tertiary structure was refined, and the most stable model, selected based on a Z-score of -4.11, was further analysed. Molecular docking revealed strong binding affinities between the vaccine construct and immune receptors, with binding free energies of -13.5 kcal/mol for Toll-like receptor 4 (TLR-4) and − 13.1 kcal/mol for HLA-A*11:01, confirming stable molecular interactions. Molecular dynamics (MD) simulations of the vaccine-TLR4 complex predicted a net binding energy of -508.0 kJ/mol, indicating high stability. Structural stabilization was enhanced by introducing four cysteine residues, forming two disulfide bonds to reduce conformational flexibility. Codon optimization (CAI: 0.58, GC content: 62.5%) indicated efficient expression in E. coli. Immune simulation demonstrated a strong Th1/Th2-skewed immune response, with significant secretion of cytokines IFN-γ, IL-2, and IL-4, supporting its efficacy in bacterial clearance. Conclusion These computational findings highlight the vaccine’s potential, though experimental validation remains necessary to confirm immunogenicity and therapeutic viability.
format Article
id doaj-art-87392eb4627d44068a5fd2c5a2794577
institution Kabale University
issn 1471-2334
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-87392eb4627d44068a5fd2c5a27945772025-08-20T03:37:19ZengBMCBMC Infectious Diseases1471-23342025-07-0125111810.1186/s12879-025-11242-5Immunoinformatics-Based development of a Multi-Epitope vaccine candidate targeting coinfection by Klebsiella pneumoniae and Acinetobacter baumanniiGul Afshan0Namrah Yaseen1Syed H Ali2Asad U. Khan3Bioinformatic Centre, Interdisciplinary Biotechnology Unit, Aligarh Muslim UniversityAntimicrobial Resistance Lab, Interdisciplinary Biotechnology Unit, Aligarh Muslim UniversityBioinformatic Centre, Interdisciplinary Biotechnology Unit, Aligarh Muslim UniversityBioinformatic Centre, Interdisciplinary Biotechnology Unit, Aligarh Muslim UniversityAbstract Background The increasing prevalence of multidrug-resistant (MDR) pathogens in clinical settings underscores the urgent need for effective therapeutic strategies. Among these, ESKAPE pathogens such as Acinetobacter baumannii and Klebsiella pneumoniae are particularly concerning due to their ability to cause severe co-infections with high resistance profiles. Methods This study utilized an immunoinformatics-driven approach to design a novel multi-epitope vaccine targeting surface proteins of these pathogens through reverse vaccinology. Computational analyses employed bioinformatics tools, including NetCTLpan 1.1, IEDB T-cell epitope prediction tool, BCPREDS, ExPASy ProtParam, Rosetta, GalaxyRefine, HADDOCK, Disulfide by Design 2, and JCAT. Results Six cytotoxic T lymphocyte (CTL), six helper T lymphocyte (HTL), and six B-cell epitopes were identified as non-allergenic, non-toxic, and highly antigenic. These epitopes were linked using GPGPG and EAAAK linkers to enhance structural flexibility and immunogenicity. The vaccine’s tertiary structure was refined, and the most stable model, selected based on a Z-score of -4.11, was further analysed. Molecular docking revealed strong binding affinities between the vaccine construct and immune receptors, with binding free energies of -13.5 kcal/mol for Toll-like receptor 4 (TLR-4) and − 13.1 kcal/mol for HLA-A*11:01, confirming stable molecular interactions. Molecular dynamics (MD) simulations of the vaccine-TLR4 complex predicted a net binding energy of -508.0 kJ/mol, indicating high stability. Structural stabilization was enhanced by introducing four cysteine residues, forming two disulfide bonds to reduce conformational flexibility. Codon optimization (CAI: 0.58, GC content: 62.5%) indicated efficient expression in E. coli. Immune simulation demonstrated a strong Th1/Th2-skewed immune response, with significant secretion of cytokines IFN-γ, IL-2, and IL-4, supporting its efficacy in bacterial clearance. Conclusion These computational findings highlight the vaccine’s potential, though experimental validation remains necessary to confirm immunogenicity and therapeutic viability.https://doi.org/10.1186/s12879-025-11242-5Antimicrobial resistanceHADDOCKImmuno-informaticsMulti-epitope vaccineReverse vaccinology
spellingShingle Gul Afshan
Namrah Yaseen
Syed H Ali
Asad U. Khan
Immunoinformatics-Based development of a Multi-Epitope vaccine candidate targeting coinfection by Klebsiella pneumoniae and Acinetobacter baumannii
BMC Infectious Diseases
Antimicrobial resistance
HADDOCK
Immuno-informatics
Multi-epitope vaccine
Reverse vaccinology
title Immunoinformatics-Based development of a Multi-Epitope vaccine candidate targeting coinfection by Klebsiella pneumoniae and Acinetobacter baumannii
title_full Immunoinformatics-Based development of a Multi-Epitope vaccine candidate targeting coinfection by Klebsiella pneumoniae and Acinetobacter baumannii
title_fullStr Immunoinformatics-Based development of a Multi-Epitope vaccine candidate targeting coinfection by Klebsiella pneumoniae and Acinetobacter baumannii
title_full_unstemmed Immunoinformatics-Based development of a Multi-Epitope vaccine candidate targeting coinfection by Klebsiella pneumoniae and Acinetobacter baumannii
title_short Immunoinformatics-Based development of a Multi-Epitope vaccine candidate targeting coinfection by Klebsiella pneumoniae and Acinetobacter baumannii
title_sort immunoinformatics based development of a multi epitope vaccine candidate targeting coinfection by klebsiella pneumoniae and acinetobacter baumannii
topic Antimicrobial resistance
HADDOCK
Immuno-informatics
Multi-epitope vaccine
Reverse vaccinology
url https://doi.org/10.1186/s12879-025-11242-5
work_keys_str_mv AT gulafshan immunoinformaticsbaseddevelopmentofamultiepitopevaccinecandidatetargetingcoinfectionbyklebsiellapneumoniaeandacinetobacterbaumannii
AT namrahyaseen immunoinformaticsbaseddevelopmentofamultiepitopevaccinecandidatetargetingcoinfectionbyklebsiellapneumoniaeandacinetobacterbaumannii
AT syedhali immunoinformaticsbaseddevelopmentofamultiepitopevaccinecandidatetargetingcoinfectionbyklebsiellapneumoniaeandacinetobacterbaumannii
AT asadukhan immunoinformaticsbaseddevelopmentofamultiepitopevaccinecandidatetargetingcoinfectionbyklebsiellapneumoniaeandacinetobacterbaumannii